Pharma Manufacturing & Solutions Special - This edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board.
We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.
“For many organizations, clinical research begins after product development is complete. At
C.L.A.I.M.S. CRO, it begins much earlier - with the claim itself” - C.L.A.I.M.S CRO
“Insight Medicare’s future roadmap brings together distribution expansion, digital engagement, talent development and differentiated formulations” - Insight Medicare
“Silamed has adopted a holistic approach to pharmaceutical growth by integrating scientific expertise, regulatory understanding, business strategy and continues innovation to deliver clinically differentiated dermatology solutions that improve patient outcomes and strengthen physician confidence” - Silamed Life Sciences
Let’s delve more into these prominent players and know how they are spearheading the...
Our subscribers play a decisive role in finalization of our annual list of Pharma Manufacturing & Solutions Special - 2026 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 |  | C.L.A.I.M.S. CRO | There was a time when product claims were largely accepted at face value. A skincare cream promised visible radiance, a nutraceutical claimed to improve immunity, or a hair serum assured stronger, healthier hair and consumers rarely questioned the science behind those statements. |
 |  | Insight Medicare | India’s pharmaceutical healthcare products manufac¬turing ecosystem has evolved into one of the most sig¬nificant pillars of the country’s healthcare economy. |
 |  | Silamed Life Sciences | According to the World Health Organization (WHO), skin diseases collectively affect nearly 1.8 billion people globally at any given time, making them among the most common human health conditions. |
